Professional
Added to YB: 2024-03-01
Pitch date: 2024-03-01
DOCS [bullish]
Doximity, Inc.
-28.88%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.
Market Cap
$3.7B
Pitch Price
$28.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
12.86
P/E
20.67
EV/Sales
4.60
Sector
Health Care Technology
Category
turnaround
(LSE:DOCS) Dr. Martens: Timeless Appeal
DOCS: UK boot brand down 80% from IPO on temporary operational/inventory issues + footwear cycle headwinds, now fixed. Strong brand w/ 13% Instagram engagement (2x competitors), higher NPS scores, multicultural appeal across genders. DTC shift from distributors driving operating leverage. FY25 est: £1B rev, 9% FCF margin, then 4-7% growth. Trading £0.92B vs £1.48B intrinsic value = 60% upside. Risks: fashion/recession.
Read full article (6 min)